InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,870.62
(
-1.32%
)
US TECH 100
19,880.00
(
-2.30%
)
Dow Jones
43,444.99
(
-0.70%
)
Brent Oil
71.25
(
0.00%
)
Bitcoin
91,118.30
(
0.59%
)
Post# of 438
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DanWebzster

Send PM Follow Ignore
Followers 10
Posts 1063
Boards Moderated 2
Alias Born 09/04/2000

DanWebzster

Member Level

Re: DanWebzster post# 208

Sunday, 06/24/2018 12:47:23 AM

Sunday, June 24, 2018 12:47:23 AM

Post# of 438
AST uses human pluripotent stem cells to treat cervical spinal cord injuries and telomerase presenting cancer cells

BTX owns 40% of AST

The reis is high, the capital is low and the updates are few

Their spinal cord injury (SCI) treatment is in Ph1/2 dose escalation study

The oncology program was initiated by the same team that discovered Imelestat. The lead treatment in this program is in Ph2 POC study in AML

Cash runway is only into Q4/18.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up